Volume 16, Issue 53 (August 2006)
J Mazandaran Univ Med Sci 2006, 16(53): 72-77 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ajami A, Abediyan F. Immunogenecity of hepatitis B vaccine in Mazandaran medical sciences students-2004. J Mazandaran Univ Med Sci 2006; 16 (53) :72-77
URL: http://jmums.mazums.ac.ir/article-1-909-en.html
URL: http://jmums.mazums.ac.ir/article-1-909-en.html
Abstract: (16412 Views)
Background and purpose: Vaccination is the most effeetive method of prophylaxy in high risk group of hepatitis B. Some individuals faile to respond to triple doses of vaccine which is potentially dangerous. Therefore, immunogenecity of triple doses recombinant hepatitis B vaccine was evaluated in a high risk group (medical sciences students).
Materials and Methods: 193 healthy medical sciences students immunized with triple doses of recombinant hepatitis B vaccine (0,1,6 months). 1-2 months after the last dose, serum anti HBS antibody was determined by ELISA method. According to the antibody titer of the vaccinees (IU/L) they were classified into none responder, low, intermediate and high responder. The none responders were recommended for re-vaccination.
Results: Three students (1.6%) were detected as non responder. (<10 Iu/L anti HBS antibody), 23 (11/4%) as low responder, 141 (73%) as intermediate responder and 26 (13.5%) as high responder.
Conclusion: The prevolence of non responders to triple doses of recombinant hepatitis B vaccine in medical sciences students was very low.
Materials and Methods: 193 healthy medical sciences students immunized with triple doses of recombinant hepatitis B vaccine (0,1,6 months). 1-2 months after the last dose, serum anti HBS antibody was determined by ELISA method. According to the antibody titer of the vaccinees (IU/L) they were classified into none responder, low, intermediate and high responder. The none responders were recommended for re-vaccination.
Results: Three students (1.6%) were detected as non responder. (<10 Iu/L anti HBS antibody), 23 (11/4%) as low responder, 141 (73%) as intermediate responder and 26 (13.5%) as high responder.
Conclusion: The prevolence of non responders to triple doses of recombinant hepatitis B vaccine in medical sciences students was very low.
Type of Study: Research(Original) |
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
